BB 008Alternative Names: BB-008
Latest Information Update: 05 Jul 2016
At a glance
- Originator Bullet Biotechnology
- Class Vaccines
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Myasthenia gravis
Most Recent Events
- 05 Jul 2016 Early research in Myasthenia gravis in USA (unspecified route)